FDA Recall Terminated Historical recordClass II
Vitamin D3 in Sesame Oil Injectable 100,000 IU/mL, 5 mL, vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,137
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,799
Class I recallsReasonable probability of serious health consequences24,349
Class II recallsTemporary or medically reversible health consequences2,891
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/berlin-seeds-recalls-alfalfa-sprouting-seed-because-possible-health-riskPublished September 23, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
FDA Recall Terminated Historical recordClass II
Tri-Test 200 (CEP 100-75-25) Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/3 mg/60 mcg/mL, a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/3 mg/100 mcg/mL, a) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/1 mg/25 mcg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/1 mg/10 mcg/mL a) 2 mL and b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 17.65 mg/0.59 mg/5.9 mcg/mL a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/2 mg/20 mcg, a) 5 mL and b) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix Injectable 30 mg/2 mg/40 mcg, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix with Atropine Injectable 30 mg/3 mg/60 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Trimix with Atropine Injectable 30 mg/3 mg/150 mcg/0.2 mg/mL, a) 2 mL b) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Tri 2 (PAP/PHEN/ATROPINE) NR Injectable, 30 mg/3 mg/0.3 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
TitanMax-MIC/12/CA/CH/L/D Injectable 25 mg/50 mg/50/0.5 mg/50 mg/25 mcg/25 mg/25 mg/mL, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Titan Up (INOS/CHOL/LEU/CAR/CHRO/LID) Injectable 25 mg/25 mg/1.5 mg/25 mg/0.025 mg/10 mg/mL, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Testosterone Propionate Injectable, 100 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Testosterone Cypionate/Anastrozole Injectable, 200 mg/1 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Testosterone Cypionate in Sesame Oil Injectable 200 mg/mL, a) 1 mL and b) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Testosterone Cypionate in Grapeseed Oil Injectable, 20 mg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Reason
- Lack of Assurance of Sterility
- Published
- January 11, 2017
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
